Addressing sickle cell disease : a strategic plan and blueprint for action /

"Sickle cell disease (SCD) is a genetic condition that affects approximately 100,000 people in the United States and millions more globally. Individuals with SCD endure the psychological and physiological toll of repetitive pain as well as side effects from the pain treatments they undergo. Som...

Full description

Saved in:
Bibliographic Details
Corporate Authors: National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action; National Academies of Sciences, Engineering, and Medicine (U.S.). Board on Population Health and Public Health Practice; National Academies of Sciences, Engineering, and Medicine (U.S.). Health and Medicine Division
Group Author: McCormick, Marie C. (Editor); Osei-Anto, Henrietta Awo (Editor); Martinez, Rose Marie, 1956- (Editor)
Published: The National Academies Press,
Publisher Address: Washington, D.C. :
Publication Dates: [2020]
Literature type: Book
Language: English
Series: A consensus study report of the National Academies of Sciences, Engineering, Medicine
Subjects:
Summary: "Sickle cell disease (SCD) is a genetic condition that affects approximately 100,000 people in the United States and millions more globally. Individuals with SCD endure the psychological and physiological toll of repetitive pain as well as side effects from the pain treatments they undergo. Some adults with SCD report reluctance to use health care services, unless as a last resort, due to the racism and discrimination they face in the health care system. Additionally, many aspects of SCD are inadequately studied, understood, and addressed. Addressing Sickle Cell Disease examines the epidemiology, health outcomes, genetic implications, and societal factors associated with SCD and sickle cell trait (SCT). This report explores the current guidelines and best practices for the care of patients with SCD and recommends priorities for programs, policies, and research. It also discusses limitations and opportunities for developing national SCD patient registries and surveillance systems, barriers in the healthcare sector associated with SCD and SCT, and the role of patient advocacy and community engagement groups." --
Carrier Form: xxv, 496 pages : illustrations (some color), color map ; 23 cm.
Bibliography: Includes bibliographical references.
ISBN: 9780309669603
030966960X
Index Number: RC641
CLC: R556.6
Call Number: R556.6/A227
Contents: Societal and structural contributors to disease impact --
Screening, registries, and surveillance --
Complications of sickle cell disease and current management approaches --
Health care organization and use --
Delivering high-quality sickle cell disease care with a prepared workforce --
Developing and delivering the next generation of therapies --
Community engagement and patient advocacy --
Strategic plan and blueprint for sickle cell disease action --